Rare diseases
Investigational molecules
Locations
3 Rue de la Porte de l'Hôpital, STRASBOURG, 67085 STRASBOURG, Alsace, France
Centre Paul Strauss in STRASBOURG, Alsace, France specialises in clinical trials of conditions such as Squamous cell carcinoma of head and neck, Breast cancer, Breast cancer female, Colorectal cancer metastatic, and other specialisations. This site conducts important research.
The medical center is at the forefront of oncology research, particularly in the treatment of head and neck cancers. The institution is pioneering studies that explore the combination of durvalumab with radiotherapy to enhance treatment efficacy and safety.
By focusing on regional control of the disease, the center aims to improve outcomes for patients with squamous cell carcinoma of the head and neck, offering innovative approaches that minimize unnecessary exposure to radiation.
More sites in STRASBOURG, AlsaceFrance
Clinical trials currently enrolling participants at this site.
Study on Pembrolizumab and Chemotherapy with Radiation for Advanced Non-Small Cell Lung Cancer Patients
FranceStudy on High-Risk Neuroblastoma Treatment with Busulfan, Melphalan, and Drug Combination for Patients with Insufficient Metastatic Response
FranceStudy on the Safety and Tolerance of Durvalumab and Radiotherapy for Patients with Untreated Head and Neck Squamous Cell Carcinoma
FranceStudy of Pembrolizumab with Drug Combination for Patients with Microsatellite Stable Metastatic Colorectal Cancer with High Immune Infiltrate
FranceStudy Comparing Avelumab, Cetuximab, and Radiotherapy with Standard Treatments for Patients with Advanced Head and Neck Squamous Cell Carcinoma
FranceStudy on Chemotherapy and Hormone Therapy for Women Over 70 with ER-Positive, HER2-Negative Breast Cancer Using Cyclophosphamide and Drug Combination
FranceStudy of platinum, pemetrexed, atezolizumab and bevacizumab combination in patients with advanced non-small cell lung cancer who have EGFR, ALK or ROS1 mutations and progressed after targeted therapy
FranceStudy on Palbociclib and Drug Combination for Patients with Hormone Receptor Positive, HER2-Positive Metastatic Breast Cancer
FranceGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
